TakeQ1 FY20

Take Q1 FY20 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹12.62P/E: 21.4Market Cap: ₹187 CrSector: Healthcare Services

Management growth scorecard

Revenue

Category 2

Margin

Category 3

Fundraise

N/A

Order

Yes

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2
  • TAKE Solutions closed the previous year at $292 million in revenue.
  • For FY2020, they expect to reach closer to $370-380 million, possibly surpassing this.
  • The company targets a long-term vision of reaching $0.5 billion in topline revenue.
  • Growth is currently above industry standards, though the high historic CQGR of around 8% may not be sustained indefinitely.
  • Recent acquisitions (KAI Research and DataCeutics) are progressing well, expected to contribute increasingly to consolidated growth.
  • The company is pursuing larger deals, with some potential contracts valued above $10 million, and up to $25 million.
  • Expansion of multi-country clinical trials is driving growth opportunities.
  • Capacity utilization is currently around 55%, and as it improves, revenue growth and cash flow generation are expected to accelerate further.

See what Take management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • No fresh loans were taken during the quarter; only normal maturities and working capital limits were used.
  • There was no loan maturity during the quarter other than normal working capital repayments.
  • The company currently does not indicate any immediate plans for raising new debt.
  • Management focus is on investing for growth rather than raising capital through buybacks or fundraising.
  • Capital expenditure for FY2020 is budgeted around 120 Crores, including asset investments and some possible intangible capitalizations.
  • No mention of any planned equity fundraising or share buyback initiatives at this time; management prefers investing in business growth.

See what Take management said on order book — free account, 30 seconds.

Capex plans

Yes
  • TAKE Solutions expects a total Capex of about 120 Crores for the fiscal year, including investments in tangible assets such as facilities, replacements, and refurbishments.
  • In Q1 FY2020, the company invested around 20 to 22 Crores in Capex.
  • Intangible asset investments (including IP) have been muted in the past two years; however, ongoing work might lead to some capitalization during the year.
  • Future investments and Capex will depend on growth and order book levels.
  • The company is investing in capacity creation to support revenue growth, currently at about 55% utilization, expecting improvements over the next two years.
  • Additional Capex is also targeted towards offshoring initiatives in newly acquired entities to improve margins.

Track Take — get its next earnings analysis in your feed

How does Take rank vs peers in Healthcare Services?

Pro feature
ThisTake
Rev 2Mar 3

How does Take rank in Healthcare Services?

Compare Take against every Healthcare Services company (Q1 FY20) on revenue, margins and earnings-call signals.

View Healthcare Services leaderboard →

Others in Healthcare Services this season

  • Chandan Healthca (Q2 FY27)

    Q2 FY27 operating income: ₹57.94 Cr, up 45.04% YoY from ₹39.95 Cr (Page 8) . Key investor presentation takeaways from Chandan Healthcare Ltd's Q2 FY27 investor

  • Invicta Diagnostic (Q2 FY27)

    Revenue from operations for the half year ended September 30, 2026: ₹379.11 lakhs (Page 4). Key results statement takeaways from Invicta Diagnostic Ltd's Q2 FY2

  • Unihealth Hosp (Q2 FY27)

    1,270 million with a year-on-year (YoY) growth of 6.3% . Key results statement takeaways from Unihealth Hospitals Ltd's Q2 FY27 results statement — and how it r

  • Sangani Hospital (Q2 FY27)

    1008.56 lakhs (~11.8% increase). Key results statement takeaways from Sangani Hospitals Ltd's Q2 FY27 results statement — and how it ranks against sector peers.

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →